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ABSTRACT
A growing body of research has uncovered that acetaminophen, the most commonly
used over-the-counter painkilling drug in the United States, produces a number of
unintended psychological effects. In particular, recent studies show that
acetaminophen blunts a variety of adaptive affective and cognitive processes,
including our sensitivity to painful social experiences and subjective responses to
emotional stimuli. Using a double-blind placebo-controlled study, here we examined
whether acetaminophen alters the early visual processing of emotional facial
expressions. Participants consumed 1000 mg of acetaminophen, or a matched
placebo, prior to performing a delayed disengagement task with different facial
expressions. Specifically, we used eye-tracking software to assess the latency to look
away from neutral, happy, and angry faces. Based on prior research, we hypothesized
that acetaminophen would reduce the typical delay in disengaging from emotional
expressions. Our findings showed a significant main effect of facial expression, with
happy faces producing the greatest delay, but there was no difference in response
between the acetaminophen and placebo conditions. These results indicate that
acetaminophen does not alter our initial assessment of emotional facial expressions,
but we suggest further research be conducted to examine how this widely consumed
drug may alter the detection and perception of emotions in others.
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INTRODUCTION
Medicinal drugs generally offer major health and societal benefits, but they
can also disrupt or inhibit mechanisms that promote adaptive fitness outcomes
(Nesse & Berrdige, 1997). For example, the unpleasantness of physical pain is highly
adaptive and critical for survival, as it draws our attention and serves to motivate
responses to alleviate the discomfort. Therefore, the routine dulling of pain from overthe-counter (OTC) drugs and other pain medications can produce a mismatch with
evolved psychological mechanisms to minimize distress (Gallup, 2019).
Acetaminophen (paracetamol, Tylenol) is the most common OTC painkiller in
the United States, with estimates suggesting that nearly one in four adults consumes
a medication containing acetaminophen each week (Kaufman et al., 2002). As an
analgesic, acetaminophen is well tolerated and effective in reducing mild to moderate
physical pain and ailments, providing relief from headaches, and reducing fever.
Acetaminophen is a weak inhibitor of the synthesis of prostaglandins, with evidence
suggesting that the analgesic effect results from activation of the descending
inhibitory serotonin pathways (e.g., Graham & Scott, 2005; Pickering et al., 2008).
While the precise mechanisms by which acetaminophen exerts an analgesic effect
remain unclear (Graham et al., 2013), it is widely accepted that this drug reduces pain
through central, rather than peripheral, nervous system mechanisms (Anderson,
2008; Courade et al., 2001; Pickering et al., 2006; Smith, 2009). The central activation
of acetaminophen means it could also produce varied psychoactive effects, i.e.,
alterations in other forms of perception, mood, cognition and behavior. In general,
psychoactive drugs bypass evolved information processing systems governing
behavior and emotions, thus potentially disengaging otherwise adaptive
psychological mechanisms and defenses (Nesse & Berrdige, 1997).
In the first study to examine the potential unintended psychological effects of
this drug, DeWall et al. (2010) investigated whether acetaminophen altered feelings
of psychosocial distress. This work was based on prior neuroimaging research
showing that both physical and social pain are processed within the same
neurobiological systems, i.e., dorsal anterior cingulate cortex and anterior insula
(Apkarian et al., 2005; Eisenberger et al., 2003; Peyron et al., 2000; Rainville et al.,
1997). Therefore, the researchers predicted that acetaminophen would reduce social
pain by attenuating neural activity within these critical brain regions. It was found that
after taking 1,000-2,000 mg of acetaminophen daily for a period of three weeks,
participants indeed reported significantly lower levels of social pain in their daily lives
and showed reduced neural activation in both the dorsal anterior cingulate cortex and
anterior insula to social rejection scenarios produced in a laboratory setting (DeWall
et al., 2010).
Subsequent research has now expanded upon these initial findings (Fung &
Alden 2017; Slavich et al. 2019), and a growing number of studies have confirmed
that even a single 1,000 mg dose of acetaminophen can reduce varied forms of
psychosocial distress. In one study, acetaminophen interrupted typical compensatory
responses to violations of expectations, also known as meaning threats (Randles et
al., 2013). For example, participants given an acute dose of acetaminophen (1,000
mg) experienced less negativity when thinking about their own mortality compared to
placebo. Single doses of acetaminophen have also been shown to reduce internal
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conflict and pain associated with some forms of decision-making (DeWall et al., 2015)
as well as reduce the perceived challenge associated with tasks designed to induce
social stress (Bershad et al., 2018).
Acetaminophen has even been shown to reduce empathy for the pain and
suffering experienced by others (Mischkowski et al., 2016). In particular, participants
administered 1,000 mg of acetaminophen showed reduced personal distress,
perceived pain, and empathic concern to hypothetical and laboratory-based scenarios
in which individuals experienced both physical and social pain. In a follow-up to this
research, the same single dose of acetaminophen also reduced affective reactivity to
the positive experiences of others (i.e., positive empathy: Mischkowski et al., 2019).
Recent research has also examined the influence of acetaminophen on social
economic interactions (Roberts et al., 2018; 2019). For example, participants with
elevated personality disorder features showed less trust compared to others when
administered a placebo, but showed increased trust (i.e., reduced distrust) when
given acetaminophen (Roberts et al., 2018).
Related research indicates that acute doses of acetaminophen can inhibit
general forms of evaluative processing through the widespread blunting of cortical
activity. In one study, participants were administered either acetaminophen or
placebo and asked to rate the positive or negative valence of a series of images, and
to respond to how much the images elicited an emotional reaction (Durso et al., 2015).
Results revealed that participants in the acetaminophen condition rated both positive
and negative images less extremely and less emotionally arousing than those in the
control condition. Consistent with these findings, recent electroencephalography
(EEG) studies have demonstrated that acetaminophen disrupts evaluative processing
in the cortex (Randles et al., 2016) and neurocognitive disengagement during off-task
attentional states (Mutti et al., 2019). Despite the growing interest in this area, there
are many unresolved and open questions regarding the psychological and
neurological effects of this commonly used OTC drug (Ratner et al., 2018).
Extending upon these recent findings, here we investigate whether
acetaminophen disrupts the early processing of emotional signals. Past research has
shown an evolved tendency for humans to prioritize and automatically orient towards
emotional facial expressions (Öhman et al., 2001; Öhman, 2002; Vuilleumier &
Schwartz, 2001). For example, happy and angry faces tend to capture and hold our
attention (Mack et al., 2002; Torrence et al., 2017). Therefore, the current study tested
whether acetaminophen modulates the initial visual processing of emotional facial
expressions using a delayed disengagement task (e.g., Belopolski et al., 2011). Given
previous research demonstrating that acute doses of acetaminophen diminish
affective responses to both positive and negative stimuli (DeWall et al., 2010; Durso
et al., 2015; Michkowski et al., 2016; 2019), we hypothesized that the administration
of this drug would reduce the typical delay in disengaging from emotional expressions.

METHODS
Participants. A total of 101 (32 female) college students participated in a
study investigating the effects of acetaminophen on various aspects of psychological
processing from November 2018 to May 2019. Recruitment occurred through the
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psychology pool and campus flyers on a public research university in Upstate New
York. The data from one participant was removed upon discovering they were 17
years of age. The remaining sample was aged 18-34 years (mean ± SD: 19.61 ±
2.71). Participants received either course research credit or $20 in compensation for
their time in the study. Exclusion criteria included any risk factors associated with
taking acetaminophen (e.g., currently taking a drug containing acetaminophen, a
history of liver disorder, an allergic reaction to acetaminophen or a history of alcohol
abuse) or a history of medical or psychiatric illness. The experiment was conducted
in accordance with approved human ethics guidelines, and all participants provided
informed consent prior to partaking in this study. The local Institutional Review Board
approved this research (#2018-08-07-1).
Design. Random assignment determined whether participants consumed a
10 ml liquid containing 1,000 mg of acetaminophen or a matched placebo solution.
Similar to Michkowski et al. (2016), acetaminophen and placebo solutions were
prepared by Pharmacy Specialists Compounding Pharmacy (Altamonte Springs,
Florida). The drug solution consisted of acetaminophen (100 mg/ml) dissolved in OraPlus suspension liquid and flavored with Ora-Sweet Syrup and the placebo solution
will consist of Avicel Microcrystalline powder (100 mg/ml) dissolved in the same
vehicle. Participants and researchers were blind to the experimental condition.
Participants were asked to refrain from eating for at least three hours prior to the
study, and following administration participants waited for a period of 60 minutes for
drug absorption (Randles et al., 2013; Durso et al., 2015).
Following the waiting period, participants were escorted to a cubicle and
positioned at a desk approximately 65cm from a Tobii Pro Spectrum 150hz eyetracker attached to a 60cm stimulus presentation monitor (EIZO FlexScan EV2451).
Following a standard 5-point calibration to assess accuracy and precision,
participants were instructed on how to perform a delayed disengagement task
modified from Belopolski et al. (2011). Specifically, participants were cued to the
center of the screen and then presented with a face positioned in between two target
boxes (one on the left; one on the right). The faces were 200 x 300 pixels at their
greatest dimensions (approximately 4.8 degrees of visual angle wide and 7.1 degrees
of visual angle high), and the offset target boxes were 300 x 300 pixels (approximately
6.3 degrees of visual angle wide and 6.3 degrees of visual angle high). Each trial
started with a fixation point at the center of the screen for 1350 ms, which was followed
by a face at the fixation point for 2000 ms and then a blank screen for 350 ms (Figure
1). Face stimuli included closed mouth depictions of neutral, happy, and angry
expressions from the NimStim face set (Tottenham et al., 2009). These images were
modified to grayscale and a uniform oval shape (which also removed hairstyles). Each
face was tilted 10o on the vertical axis, and participants were instructed to look at the
box in the congruent direction of the tilted face as quickly as possible. Hence, if the
face was tilted to the left, participants had to fixate on the box on the left (see Figure
1). Both boxes included a target dot which was 742 pixels from the center of the
screen. A predefined area of interest (AOI) was drawn over each of the boxes
(overlapping the edges by 50 pixels, or approximately 13.4 mm), and responses were
measured by the latency (in milliseconds) to fixate on the AOI of the congruent box.
Participants were informed that the expression of the face was irrelevant to the task.
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Figure 1. Depiction of the focal point and stimulus presentation for the delayed disengagement
task. Represented above is an angry female face tilted to the left; during this trial, participants
would avert their attention and fixate on the left box as quickly as possible.

Prior to testing, participants completed 12 practice trials to become familiar
with the task. These trials portrayed one male face and one female face in all possible
combinations (3 expressions x 2 vertical orientations), and participants received
verbal feedback on their performance from a researcher running the session from the
other side of a partition. Following the practice trials, participants then completed 96
testing trials separated by a break at the midpoint. These trials portrayed eight male
and eight female faces in all possible combinations, with the order randomized prior
to testing. Participants were encouraged to respond as quickly and accurately as
possible during all trials.
Analysis. During data collection, five participants indicated having an eye
condition and/or produced high inaccuracy or imprecision during calibration, and
therefore were not included in the analysis. In addition, based on research indicating
the time needed before a programed eye movement is launched (e.g., Matin et al.,
1993), any trial responses that occurred before 200 ms were excluded from the
analysis. Moreover, the data from an entire participant were excluded from the
analysis if the individual responded too early (< 200 ms) or too late (> 2000 ms) on
more than five of the 96 trials during testing. This included 5% of the total sample
(5/100).
The final sample consisted of 90 participants (43 acetaminophen; 47 placebo),
all with normal or corrected to normal vision. We ran a mixed-effect ANOVA with facial
expression (neutral, angry, or happy) as a within-subject factor and drug treatment
(acetaminophen or placebo) as a between-subject factor. A post hoc power analysis
was performed for this design using G*Power 3.1, indicating power of 0.846 to detect
a small effect. All statistics were conducted in SPSS, with the alpha set to 0.05.
EvoS Journal: The Journal of the Evolutionary Studies Consortium
ISSN: 1944-1932 - http://evostudies.org/evos-journal/about-the-journal/
2020, NEEPS XIII, pp. 34-43.

-38-

Acetaminophen and the Processing of Facial Expressions

Figure 2. Fixation latencies varied significantly across the three facial expressions (p < 0.05),
but there was no difference between the acetaminophen and placebo conditions. M ± 95% CI
represented above.

RESULTS
Analyses revealed a significant main effect of facial expression (F2,176 = 3.927,
p = 0.021, partial eta2 = 0.043; Figure 2). Post hoc tests revealed that disengagement
away from the angry faces was significantly faster compared to both happy faces (p
= 0.008) and neutral faces (p = 0.042). However, there was absolutely no difference
between conditions with regards to drug treatment (F1,88 = 0.000, p = 0.983, partial
eta2 = 0.000). Moreover, there was no interaction between the facial expression and
drug treatment conditions (F2,176 = 1.018, p = 0.364, partial eta2 = 0.011). Therefore,
acetaminophen did not appear to alter visual processing in this task.

DISCUSSION
A growing number of studies have reported distinct psychological effects
resulting from the consumption of acetaminophen (reviewed by Ratner et al., 2018).
Based on previous work showing that acetaminophen blunts affective responses to
positive and negative stimuli (e.g., DeWall et al., 2010; Durso et al., 2015; Michkowski
et al., 2016; 2019), this study examined whether this drug influences the early
processing of emotional facial expressions. Contrary to our predictions, participants
in both the acetaminophen and placebo groups responded similarly across facial
expression conditions.
Prior imaging studies have shown that acetaminophen attenuates activity
within cortical areas involved in the rapid processing of emotional facial expressions
(i.e., the anterior cingulate cortex: DeWall et al., 2010; Fan et al., 2011; Pickering et
al., 2015). However, a large number of cortical and subcortical structures become
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active during the early processing of emotional faces (e.g., Adolphs, 2002; Fan et al.,
2011; Habel et al., 2007; LeDoux, 1995; Morris et al., 1999), and the null effects
reported here may be due to greater subcortical activation during the disengagement.
In other words, it is possible that the test we used incorporates brain areas that are
so evolutionarily conserved, due to the necessity of quickly processing emotions via
the face, that the neuromodulation from acetaminophen fails to alter this prewired
adaptation. In addition, the nature of focusing on the vertical orientation of the facial
stimuli could recruit other brain regions not affected by acetaminophen. Therefore,
future research could more explicitly investigate whether this drug modulates the
evaluation of more complex emotional states in others. Based on studies showing
that acetaminophen inhibits the activation of some emotions (e.g., DeWall et al., 2010;
Randles et al., 2013), it would also be interesting to assess whether this OTC drug
blunts facial affect display.
Across drug treatment conditions, our results show that happy faces produced
the slowest disengagement and angry faces produced the fastest disengagement.
These findings are in contrast to those reported in Belopolski et al. (2011), which
showed slowest disengagement from angry expressions and no difference between
happy and neutral faces. It is not clear why our results differ, particularly given the
backdrop of literature showing that biologically threatening stimuli capture attention
(e.g., Öhman et al., 2001; Öhman & Mineka, 2001). However, one key distinction in
methods is that Belopolski et al. (2011) used schematic faces with more dramatic
cues of happiness and anger, while the current study included photographs of people
displaying subtle, closed mouth depictions of these emotions (Tottenham et al.,
2009). Therefore, it remains possible that the more overt “open mouth stimuli” from
the NimStim image set would produce different effects. Nonetheless, prior works have
shown that happiness captures attention (Mack et al., 2002; Miyazawa, & Iwasaki,
2010; Torrence et al., 2017), and the main effect observed here is consistent with this
literature.
In summary, the results of this study suggest that an acute dose of
acetaminophen does not alter the early processing of emotional facial expressions.
However, due to limitations in the current approach, we propose that research
continue to explore how acetaminophen may alter both the detection and perception
of emotion in others. With tens of millions of Americans consuming acetaminophen
each week, it is critical for researchers to study the full range of psychological effects
produced by this drug if we hope to understand how it influences real-world
interactions and interpersonal relationships. Moreover, further research should
explore how chronic use of this drug may alter different aspects of
neurological/psychological processing. In particular, we believe that further
evolutionary inspired research like this could provide important insight into
understanding how this common OTC painkiller produces a mismatch with our
evolved psychology (Gallup, 2019).
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